Skip to content
naulon

Not checkedNot checked for notices yet.

Correlation analysis between mood disorders and imaging biomarkers in patients with arteriosclerotic cerebral small vessel disease

Jiang Yuxuan, Lin Jiahao, Liu Sanxin, Liu Xu, Liu Yuxin, Lu Zhengqi, Lu Tingting

Xin yixue · 2022

doi:10.3969/j.issn.0253-9802.2022.10.013 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Objective To investigate the correlation between mood disorders and imaging markers in patients with arteriosclerotic cerebral small vessel disease (aCSVD), aiming to provide evidence for clinical diagnosis, treatment and mechanism. Methods Eighty-one aCSVD patients were included in this study. According to the Self-Rating Anxiety Scale (SAS) and Self-Rating Depression Scale (SDS) scores, all patients were divided into the non-anxiety (n = 58), anxiety (n = 23), non-depression (n = 50) and depression groups (n = 31). The correlation between CSVD imaging markers and anxiety and depression was analyzed. Results The average age of patients was (67.03±9.28) years. The CSVD imaging burden score was 1.5 (2). Among imaging markers, the number of basal ganglia enlarged perivascular space (BG-EPVS) was independently associated with anxiety (P = 0.004) and depression (P = 0.011). Symptomatic analysis showed that the number of BG-EPVS was correlated with the anxiety symptoms, such as frequent urination (P = 0.026), facial flushing and perspiration (P = 0.007), sleep disturbance (P = 0.002), and negative ideational content of depression (P < 0.001). Conclusions Among different CSVD imaging markers, BG-EPVS is independently associated with anxiety and depression in aCSVD patients. For anxiety, BG-EPVS is correlated with anxiety-related somatical symptoms and sleep disorders. For depression, BG-EPVS mainly affects the psychological state of aCSVD patients. aCSVD patients with a significantly increasing number of BG-EPVS are more likely to develop mood disorders, and early interventions may bring benefits to aCSVD patients.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.